The SNM1/Pso2 family of ICL repair nucleases: from yeast to man. by Cattell, E, Sengerová, B, McHugh, P

Systemic treatment of colorectal cancer. by Tebbutt, N, Cattell, E, Midgley, R, Cunningham, D, Kerr, D

Cell cycle regulatory proteins as therapeutic targets: A validated method for pharmacodynamic evaluation of clinical trials by Bradbury, P, Norbury, C, Olsen, A, Slade, M, Cattell, E, Talbot, D

A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancer. by Talbot, D, von Pawel, J, Cattell, E, Yule, S, Johnston, C, Zandvliet, A, Huitema, A, Norbury, C, Ellis, P, Bosquee, L, Reck, M

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair by Wang, A, Sengerová, B, Cattell, E, Inagawa, T, Hartley, J, Kiakos, K, Burgess-Brown, N, Swift, L, Enzlin, J, Schofield, C, Gileadi, O, Hartley, J, McHugh, P

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. by Wang, A, Sengerová, B, Cattell, E, Inagawa, T, Hartley, J, Kiakos, K, Burgess-Brown, N, Swift, L, Enzlin, J, Schofield, C, Gileadi, O, Hartley, J, McHugh, P

Quinone oxidoreductase-2-mediated prodrug cancer therapy. by Middleton, MR, Knox, R, Cattell, E, Oppermann, U, Midgley, R, Ali, R, Auton, T, Agarwal, R, Anderson, D, Sarker, D, Judson, I, Osawa, T, Spanswick, V, Davies, S, Hartley, J, Kerr, D